Oncology Archives - Page 5 of 5 - Corcept Therapeutics

Mifepristone inhibits GRβ coupled prostate cancer cell proliferation.

September 18, 2018

Ligr et al. • 2012 • J Urol. 2012;188(3):981-8.

Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.

September 18, 2018

Tieszen et al. • 2011 • BMC Cancer. 2011;11:207.

Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.

September 18, 2018

Yan et al. • 2008 • Urol Int. 2008;81(2):228-33.

Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro.

September 18, 2018

Zhang et al. • 2008 • Zhonghua Wai Ke Za Zhi. 2006;44(6):382-5.

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.

September 18, 2018

Nanda et al. • 2016 • Springerplus. 2016;5(1):947.

Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer.

September 18, 2018

Baker et al. • 2015 • Cancer Manag Res. 2015;7:361-8.

A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer

September 18, 2018

Nanda et al. • 2013 • Cancer Res 2013;73(24 Suppl): Abstract nr P2-16-21.

High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer

November 15, 2017

Veneris et al • 2017 • Gynecol Oncol.

Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes SGK1 and MKP1/DUSP1 in Ovarian Tissues

November 15, 2009

Melhem et al • 2009 • Clin Cancer Res.